364 Chapter 12 73. Dauvilliers Y, Bauer J, Rigau V, Lalloyer N, Labauge P, Carlander B, et al. Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy. JAMA Neurol. 2013;70(10):1305-10. 74. Cogswell AC, Maski K, Scammell TE, Tucker D, Orban ZS, Koralnik IJ. Children with Narcolepsy type 1 have increased T-cell responses to orexins. Ann Clin Transl Neurol. 2019;6(12):2566-72. 75. Pedersen NW, Holm A, Kristensen NP, Bjerregaard AM, Bentzen AK, Marquard AM, et al. CD8(+) T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens. Nat Commun. 2019;10(1):837. 76. Gool JK, Cross N, Fronczek R, Lammers GJ, van der Werf YD, Thanh DVT. Neuroimaging in Narcolepsy and Idiopathic Hypersomnia: from Neural Correlates to Clinical Practice. Curr Sleep Med Rep. 2020;6(4):251-66. 77. Buskova J, Vaneckova M, Sonka K, Seidl Z, Nevsimalova S. Reduced hypothalamic gray matter in narcolepsy with cataplexy. Neuro Endocrinol Lett. 2006;27(6):76972. 78. Draganski B, Geisler P, Hajak G, Schuierer G, Bogdahn U, Winkler J, May A. Hypothalamic gray matter changes in narcoleptic patients. Nat Med. 2002;8(11):1186-8. 79. Joo EY, Tae WS, Kim ST, Hong SB. Gray matter concentration abnormality in brains of narcolepsy patients. Korean J Radiol. 2009;10(6):552-8. 80. Kim SJ, Lyoo IK, Lee YS, Lee JY, Yoon SJ, Kim JE, et al. Gray matter deficits in young adults with narcolepsy. Acta Neurol Scand. 2009;119(1):61-7. 81. Weng HH, Chen CF, Tsai YH, Wu CY, Lee M, Lin YC, et al. Gray matter atrophy in narcolepsy: An activation likelihood estimation meta-analysis. Neurosci Biobehav Rev. 2015;59:53-63. 82. Kaufmann C, Schuld A, Pollmacher T, Auer DP. Reduced cortical gray matter in narcolepsy: preliminary findings with voxel-based morphometry. Neurology. 2002;58(12):1852-5. 83. Overeem S, Steens SC, Good CD, Ferrari MD, Mignot E, Frackowiak RS, et al. Voxelbased morphometry in hypocretin-deficient narcolepsy. Sleep. 2003;26(1):44-6. 84. Scherfler C, Frauscher B, Schocke M, Nocker M, Gschliesser V, Ehrmann L, et al. White and gray matter abnormalities in narcolepsy with cataplexy. Sleep. 2012;35(3):345-51. 85. Brenneis C, Brandauer E, Frauscher B, Schocke M, Trieb T, Poewe W, Hogl B. Voxel-based morphometry in narcolepsy. Sleep Med. 2005;6(6):531-6. 86. Juvodden HT, Alnaes D, Lund MJ, Agartz I, Andreassen OA, Server A, et al. Larger hypothalamic volume in narcolepsy type 1. Sleep. 2023;46(11). 87. Joo EY, Jeon S, Lee M, Kim ST, Yoon U, Koo DL, et al. Analysis of cortical thickness in narcolepsy patients with cataplexy. Sleep. 2011;34(10):1357-64. 88. Tondelli M, Pizza F, Vaudano AE, Plazzi G, Meletti S. Cortical and Subcortical Brain Changes in Children and Adolescents With Narcolepsy Type 1. Sleep. 2018;41(2). 89. Schaer M, Poryazova R, Schwartz S, Bassetti CL, Baumann CR. Cortical morphometry in narcolepsy with cataplexy. J Sleep Res. 2012;21(5):487-94. 90. Juvodden HT, Alnaes D, Agartz I, Andreassen OA, Server A, Thorsby PM, et al. Cortical thickness and sub-cortical volumes in post-H1N1 narcolepsy type 1: A brain-wide MRI case-control study. Sleep Med. 2024;116:81-9. 91. Moraes M, Rossini S, Reimao R. Executive attention and working memory in narcoleptic outpatients. Arq Neuropsiquiatr. 2012;70(5):335-40. 92. Rieger M, Mayer G, Gauggel S. Attention deficits in patients with narcolepsy. Sleep. 2003;26(1):36-43.
RkJQdWJsaXNoZXIy MjY0ODMw